CDC

Push to expand participation in vaccine program doubles RSV dose orders nationwide

November 21, 2025

A CDC-led initiative with health departments and professional groups increased birthing hospital enrollment in the Vaccines for Children (VFC) program from 763 facilities (27.1%) at the start of the 2023–24 RSV season to 1,021 (36.2%) by the end of 2024–25. The number of nirsevimab doses ordered approximately doubled, signaling greater access to RSV immunization for eligible infants before discharge. Expanded participation is expected to strengthen protection during peak RSV seasons.

Clinical takeaway: Continued efforts to increase birthing hospital VFC enrollment can support expanded access to RSV immunization.

Source:

Olmsted KE, et al. (2025, November 20). CDC. Notes from the Field: Expanding Birthing Hospital Enrollment in the Vaccines for Children Program to Increase Infant Immunization Against Respiratory Syncytial Virus — United States, October 2023–March 2025. https://www.cdc.gov/mmwr/volumes/74/wr/mm7437a2.htm